Skip to content
Biodatica
Start free

Blue Earth Diagnostics

Dallas, Texas

OncologyFiled/Approved
Compare Sign in to watch

What changed

Study registered, no phase assigned: Rethinking Early Airway Clearence Therapies

1w agoTrial registeredJul 10, 2026Source filing (opens the source filing in a new tab)

Momentum

88no change

Momentum 88 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Filed/Approved

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

72 pre-ticker oncology companies at Filed/Approved

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Sep 15, 2026

    Cystic Fibrosis (CF) · NOT_YET_RECRUITING · sponsor: Nicole Hamblett · Rethinking Early Airway Clearence Therapies

    ClinicalTrials.gov · NCT07696338 (opens the source filing in a new tab)

  2. Trial

    PHASE1/PHASE2 registered

    Feb 19, 2026

    Colorectal Cancer, Epithelial Ovarian Cancer, Gastric Cancer, Invasive Lobular Breast Carcinoma, Pancreatic Ductal Adenocarcinoma · RECRUITING · sponsor: Blue Earth Diagnostics · [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

    ClinicalTrials.gov · NCT07432633 (opens the source filing in a new tab)

  3. Trial

    Study registered

    Jun 11, 2021

    Cystic Fibrosis, Cystic Fibrosis in Children · COMPLETED · sponsor: Nicole Hamblett · The PROMISE Pediatric Study 6 to 11 Years Old

    ClinicalTrials.gov · NCT04613128 (opens the source filing in a new tab)

  4. Trial

    PHASE4 registered

    Dec 1, 2018

    Cystic Fibrosis · TERMINATED · sponsor: University of Alabama at Birmingham · Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations

    ClinicalTrials.gov · NCT03624101 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources